Jorn L. J. C. Assmann

Detecting measurable residual disease beyond 10−4 by an IGHV leader-based NGS approach improves prognostic stratification in CLL

Paul J. Hengeveld, Michèle Y. van der Klift, P. Martijn Kolijn et al. · Blood · 2022 · 24 citations · Full text

Medicine, Bioinformatics, Molecular Medicine +14

miR-181a is a novel player in the STAT3-mediated survival network of TCRαβ+ CD8+ T large granular lymphocyte leukemia

Jorn L. J. C. Assmann, Leticia G. León, Christiaan J. Stavast et al. · Leukemia · 2021 · 21 citations · Full text

Life Sciences, Cell Biology, Immunology +15

Extensive longitudinal immune profiling reveals sustained innate immune activaton in COVID-19 patients with unfavorable outcome

Benjamin Schrijver, Jorn L. J. C. Assmann, Adriaan J. van Gammeren et al. · European Cytokine Network · 2020 · 15 citations · Full text

Life Sciences, Immunology, Infectious Diseases +17